Evidence map›Paper›PMID 41252366›Full record

ArticlePloS one2025

Exploring cardiovascular disease prevalence and contributing factors among adults in Southern Iran, a cross-sectional survey: Rationale, design, and primary results.

Hossein Farshidi, Marzieh Nikparvar, Shokrollah Mohseni, Ebrahim Eftekhar, Farideh Dastsouz, Abdoljabbar Zakeri, Mohammad Mohammadi, Farkhondeh Razmpour, Farid Khorrami, Masoumeh Mahmoodi and 5 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hossein FarshidiCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Marzieh NikparvarCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Shokrollah MohseniSocial Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Ebrahim EftekharMolecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Farideh DastsouzCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Abdoljabbar ZakeriCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Mohammad MohammadiFood Health Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Farkhondeh RazmpourFood Health Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Farid KhorramiHealth Information Technology, Faculty of Paramedicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Masoumeh MahmoodiCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Nahid ShahabiCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Soghra FallahiCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Atefeh GhareghaniCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Najmeh ShanbehzadehDepartment of Oral and Maxillofacial Medicine, School of Dentistry, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Shahin AbbaszadehCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.ORCID https://orcid.org/0000-0003-0211-3829

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesCardiovascular disease (CVD) is the primary cause of death worldwide, with significant fatalities reported in Iran. Hormozgan Province in southern Iran faces serious public health challenges related to CVD, a major cause of morbidity and mortality in the region. This study investigates the prevalence of CVD and its contributing factors in this region.

methodThis cross-sectional study was conducted in Hormozgan Province, southern Iran, from June 21 to December 21, 2023. A total of 6289 individuals aged 20 and older were selected through random multistage sampling techniques. Data collection involved three phases: administering a comprehensive questionnaire, measuring anthropometric data and blood pressure, and conducting laboratory blood tests. CVD was defined as the presence of ischemic heart disease (IHD) or ischemic and hemorrhagic strokes. Data analysis was performed using SPSS version 26, incorporating statistical tests such as multivariable logistic regression, Mann-Whitney tests, and Chi-square to compare groups.

resultsA total of 6289 participants were included in the study, with a mean age of 45.63 ± 15.04 years. Among them, 58.5% were female, and 51.6% lived in urban areas. Key findings revealed that 45.7% of the population were identified as overweight or obese, with a significant prevalence of abdominal obesity at 69.6%, particularly among females. The prevalence of CVD in the population was 7.8%, with IHD affecting 6.7% of individuals and stroke affecting 2.2%. Multivariable logistic regression identified increased age (AOR: 1.03; 95% CI: 1.02-1.04), higher body mass index (BMI) (AOR: 1.02; 95% CI: 1.00-1.05), hypercholesterolemia (AOR: 1.30; 95% CI: 1.03-1.66), hypertension (HTN) (AOR: 2.02; 95% CI: 1.55-2.64), diabetes (AOR: 1.31; 95% CI: 1.00-1.71), and severe anxiety (AOR: 2.39; 95% CI: 1.30-4.39) as significant risk factors for CVD. Women had a 33% lower risk of having CVD compared to men (AOR: 0.67; 95% CI: 0.53-0.85).

conclusionThis study highlights urgent public health concerns in Hormozgan Province, including high rates of CVD, obesity, abnormal blood pressure, and diabetes, particularly among females, underlining the need for targeted health interventions and improved nutritional practices.

Indexed as

Cardiovascular DiseasesAdultAgedBody Mass IndexCross-Sectional StudiesFemaleHumansIranMaleMiddle AgedObesity, AbdominalPrevalenceRisk FactorsSurveys and QuestionnairesYoung Adult

Identifiers

PMID41252366
PMCPMC12626332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.